


Healthcare News Roundup: Regulatory
HSMN NewsFeed - 28 Oct 2013
SpineGuard Obtains Regulatory Clearance to Sell Pediguard(R) Curved and Curved XS in Mexico
SpineGuard Obtains Regulatory Clearance to Sell Pediguard(R) Curved and Curved XS in Mexico
HSMN NewsFeed - 22 Oct 2013
Gentium Receives Marketing Authorization From the European Commission for Defitelio(R) (Defibrotide)
Gentium Receives Marketing Authorization From the European Commission for Defitelio(R) (Defibrotide)
HSMN NewsFeed - 15 Oct 2013
Second Draft NICE Guidance for Aggressive non-Hodgkin Lymphoma Treatment, PIXUVRI(R) (pixantrone)
Second Draft NICE Guidance for Aggressive non-Hodgkin Lymphoma Treatment, PIXUVRI(R) (pixantrone)
HSMN NewsFeed - 14 Oct 2013
St. Jude Medical Announces Acquisition and CE Mark Approval of World's First Leadless Pacemaker
St. Jude Medical Announces Acquisition and CE Mark Approval of World's First Leadless Pacemaker
HSMN NewsFeed - 9 Oct 2013
Preventice, Inc. Receives CE Mark for BodyGuardian Remote Monitoring System
Preventice, Inc. Receives CE Mark for BodyGuardian Remote Monitoring System
HSMN NewsFeed - 3 Oct 2013
Valeant Pharmaceuticals Announces Approval Of Jublia(R) For The Treatment Of Onychomycosis In Canada
Valeant Pharmaceuticals Announces Approval Of Jublia(R) For The Treatment Of Onychomycosis In Canada
HSMN NewsFeed - 2 Oct 2013
KLOX Technologies Announces Approval in Canada of its Innovative Acne Vulgaris Treatment
KLOX Technologies Announces Approval in Canada of its Innovative Acne Vulgaris Treatment
HSMN NewsFeed - 23 Sep 2013
Bayer receives approval for Adempas(R) as first drug to treat rare heart and lung disease
Bayer receives approval for Adempas(R) as first drug to treat rare heart and lung disease
HSMN NewsFeed - 23 Sep 2013
Given Imaging Receives Clearance for the Third Generation PillCam(R) SB System in Japan
Given Imaging Receives Clearance for the Third Generation PillCam(R) SB System in Japan
HSMN NewsFeed - 20 Sep 2013
RELVAR(TM) ELLIPTA(TM) Gains Approval in Japan for the Treatment of Asthma
RELVAR(TM) ELLIPTA(TM) Gains Approval in Japan for the Treatment of Asthma
HSMN NewsFeed - 17 Sep 2013
Abbott Receives CE Mark for FreeStyle Optium Neo Blood Glucose and Ketone Monitoring System(TM)
Abbott Receives CE Mark for FreeStyle Optium Neo Blood Glucose and Ketone Monitoring System(TM)
HSMN NewsFeed - 17 Sep 2013
Dendreon Announces Marketing Authorization for PROVENGE(R) in the European Union
Dendreon Announces Marketing Authorization for PROVENGE(R) in the European Union
HSMN NewsFeed - 17 Sep 2013
European Commission Approves Genzyme’s Multiple Sclerosis Treatment Lemtrada(TM) (alemtuzumab)
European Commission Approves Genzyme’s Multiple Sclerosis Treatment Lemtrada(TM) (alemtuzumab)
HSMN NewsFeed - 13 Sep 2013
Alexion's Soliris(R) (eculizumab) Receives Marketing Approval in Japan for All Patients with aHUS
Alexion's Soliris(R) (eculizumab) Receives Marketing Approval in Japan for All Patients with aHUS
HSMN NewsFeed - 9 Sep 2013
Keystone Heart's TriGuard(TM) Cerebral Protection Device Receives CE Marking
Keystone Heart's TriGuard(TM) Cerebral Protection Device Receives CE Marking
